EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth ...

This article was reviewed by Felix Gussone, MD. What Is Testosterone? As the primary male hormone, or androgen, testosterone ...

Testosterone is the primary androgen — or male hormone — in your body. Low testosterone affects up to 39 percent ...

MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has relaunched ORGOVYX ® ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...

The country music icon has battled a number of health struggles throughout her career, and the moment she collapsed on stage ...

The latest update is out from Kissei Pharmaceutical Co ( (JP:4547) ).

The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, ...

Branded Medicines Division today announced it has entered into a strategic licensing agreement securing exclusive Canadian ...

Alberta's premier says her government might invoke the notwithstanding clause to defend laws affecting transgender people ...

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV ...

Alberta's premier says her government might invoke the notwithstanding clause to defend laws affecting transgender people because courts may take "years and years and years" to resolve the issue, and ...